These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 21059349

  • 1. Falsely elevated tacrolimus concentrations measured using the ACMIA method due to circulating endogenous antibodies in a kidney transplant recipient.
    D'Alessandro M, Mariani P, Mennini G, Severi D, Berloco P, Bachetoni A.
    Clin Chim Acta; 2011 Jan 30; 412(3-4):245-8. PubMed ID: 21059349
    [Abstract] [Full Text] [Related]

  • 2. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
    Toraishi T, Takeuchi H, Nakamura Y, Konno O, Yokoyama T, Iwamoto H, Hama K, Hirano T, Unezaki S, Okuyama K, Shimazu M.
    Transplant Proc; 2012 Jan 30; 44(1):134-6. PubMed ID: 22310597
    [Abstract] [Full Text] [Related]

  • 3. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
    Rostaing L, Cointault O, Marquet P, Josse AG, Lavit M, Saint-Marcoux F, Kamar N.
    Transpl Int; 2010 Feb 30; 23(2):227-30. PubMed ID: 19761555
    [Abstract] [Full Text] [Related]

  • 4. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results.
    Hermida J, Tutor JC.
    Ther Drug Monit; 2009 Apr 30; 31(2):269-72. PubMed ID: 19258927
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A.
    J Pharm Biomed Anal; 2010 Dec 01; 53(4):997-1002. PubMed ID: 20674215
    [Abstract] [Full Text] [Related]

  • 6. Specificity of a circulating antibody that interferes with a widely used tacrolimus immunoassay.
    Parikh BA, Siedlecki AM, Scott MG.
    Ther Drug Monit; 2010 Apr 01; 32(2):228-31. PubMed ID: 20216109
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the plasma concentration of tacrolimus: a useful method for distinguishing falsely elevated tacrolimus concentrations reported by the ACMIA.
    Yamaoka M, Kawamura R, Shioda Y, Ogawa N, Koyama I, Saitoh T, Ikebuchi K.
    Rinsho Byori; 2010 Dec 01; 58(12):1188-92. PubMed ID: 21344794
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand dimension.
    Barau C, Frangie C, Goujard C, Tribut O, Parant F, Taburet AM, Durrbach A, Furlan V.
    Ther Drug Monit; 2009 Apr 01; 31(2):267-8. PubMed ID: 19214146
    [Abstract] [Full Text] [Related]

  • 10. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK, Chang HK, Kim HJ, Huh KH, Ahn HJ, Kim MS, Kim SI, Kim YS.
    Transplant Proc; 2008 Dec 01; 40(10):3673-8. PubMed ID: 19100463
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Falsely elevated tacrolimus levels caused by immunoassay interference secondary to beta-galactosidase antibodies in an infected liver transplant recipient.
    Knorr JP, Grewal KS, Balasubramanian M, Young N, Zaki R, Khanmoradi K, Araya V, Ortiz J.
    Pharmacotherapy; 2010 Sep 01; 30(9):954. PubMed ID: 20812435
    [Abstract] [Full Text] [Related]

  • 15. Apparent elevation of cyclosporine whole blood concentrations in a renal allograft recipient.
    de Jonge H, Geerts I, Declercq P, de Loor H, Claes K, Desmet K, Kuypers DR.
    Ther Drug Monit; 2010 Oct 01; 32(5):529-31. PubMed ID: 20625351
    [Abstract] [Full Text] [Related]

  • 16. Comparison of antibody-conjugated magnetic immunoassay and liquid chromatography-tandem mass spectrometry for the measurement of cyclosporine and tacrolimus in whole blood.
    Cangemi G, Barco S, Bonifazio P, Maffia A, Agazzi A, Melioli G.
    Int J Immunopathol Pharmacol; 2013 Oct 01; 26(2):419-26. PubMed ID: 23755756
    [Abstract] [Full Text] [Related]

  • 17. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS, Taylor PJ, Salm P, Morris RG.
    Ther Drug Monit; 2007 Oct 01; 29(5):584-91. PubMed ID: 17898648
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rheumatoid factor interference in a tacrolimus immunoassay.
    Barceló Martín B, Marquet P, Ferrer JM, Castanyer Puig B, Barcelo Bennasar A, Riesco Prieto M, Fortuny Marqués R.
    Ther Drug Monit; 2009 Dec 01; 31(6):743-5. PubMed ID: 19935362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.